Metralindole
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C15H17N3O |
Molar mass | 255.32 g/mol |
3D model (Jmol) | |
|
Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.
See also[edit]
References[edit]
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |